Effects of short- and long-term Mediterranean-based dietary treatment on plasma LC-QTOF/MS metabolic profiling of subjects with metabolic syndrome features: The Metabolic Syndrome Reduction in Navarra (RESMENA) randomized controlled trial

Molecular Nutrition and Food Research

Volumn 59, Issue 4, 2015, Pages 711-728

  Bondia Pons, Isabel ^a,b   Martinez, José Alfredo ^b,c   de la Iglesia, Rocio ^b   Lopez Legarrea, Patricia ^b,d   Poutanen, Kaisa ^a,e   Hanhineva, Kati ^e   Zulet, Maria de los Ángeles ^b,c  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b UNIVERSITY OF NAVARRA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE CHILE   (Chile)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Dependency networks; LC QTOF MS; Mediterranean diet; Metabolic syndrome; Metabolomics

Indexed keywords

BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; BLOOD; BODY MASS; BODY WEIGHT; CAUCASIAN; CONTROLLED STUDY; DIET THERAPY; HUMAN; MASS SPECTROMETRY; MEDITERRANEAN DIET; METABOLIC SYNDROME X; METABOLOME; METABOLOMICS; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR;

ADULT; BIOMARKERS; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, MEDITERRANEAN; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MASS SPECTROMETRY; METABOLIC SYNDROME X; METABOLOME; METABOLOMICS; TIME FACTORS; TRIGLYCERIDES;

EID: 84926097961     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400309     Document Type: Article

References (54)

1. Eckel, R. H. Grundy, S. M. Zimmet, P. Z. The metabolic syndrome. Lancet 2005, 365, 1415-1428.
2. Kastorini, C. M. Milionis, H. J. Esposito, K. Giugliano, D. et al. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534906 individuals. J. Am. Coll. Cardiol. 2011, 57, 1299-1313.
3. Estruch, R. Ros, E. Martínez-González, M. A. Mediterranean diet for primary prevention of cardiovascular disease. N. Engl. J. Med. 2013, 369, 676-677.
4. Mitjavila, M. T. Fandos, M. Salas-Salvadó, J. Covas, M. I. et al. The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. A randomized, controlled trial. Clin. Nutr. 2013, 32, 172-178.
5. Urpi-Sarda, M. Casas, R. Chiva-Blanch, G. Romero-Mamani, E. S. et al. The Mediterranean diet pattern and its main components are associated with lower plasma concentrations of tumor necrosis factor receptor 60 in patients at high risk for cardiovascular disease. J. Nutr. 2012, 142, 1019-1025.
6. Richard, C. Couture, P. Ooi, E. M. Tremblay, A. J. et al. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 433-438.
7. Panunzio, M. F. Caporizzi, R. Antoniciello, A. Cela, E. P. et al. Randomized, controlled nutrition education trial promotes a Mediterranean diet and improves anthropometric, dietary, and metabolic parameters in adults. Ann. Ig. 2011, 23, 13-25.
8. Lopez-Legarrea, P. de la Iglesia, R. Abete, I. Bondia-Pons, I. et al. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial. Nutr. Metab. 2013, 10, 15-22.
9. de la Iglesia, R. Lopez-Legarrea, P. Abete, I. Bondia-Pons, I. et al. A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project. Br. J. Nutr. 2014, 111, 643-652.
10. de la Iglesia, R. Lopez-Legarrea, P. Celada, P. Sánchez-Muniz, F. J. et al. Beneficial effects of the RESMENA dietary pattern on oxidative stress in patients suffering from metabolic syndrome with hyperglycemia are associated to dietary TAC and fruit consumption. Int. J. Mol. Sci. 2013, 14, 6903-6919.
11. de la Iglesia, R. Lopez-Legarrea, P. Crujeiras, A. B. Pardo, M. et al. Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients. Clin. Endocrinol. 2014, 81, 306-311.
12. Patti, G. J. Yanes, O. Siuzdak, G. Innovation: metabolomics: the apogee of the omics trilogy. Nat. Rev. Mol. Cell Biol. 2012, 13, 263-269.
13. Bondia-Pons, I. Pöhö, P. Bozzetto, L. Vetrani, C. et al. Isoenergetic diets differing in their n-3 fatty acid and polyphenol content reflect different plasma and HDL-fraction lipidomic profiles in subjects at high cardiovascular risk. Mol. Nutr. Food Res. 2014, 58, 1873-1882.
14. Bondia-Pons, I. Maukonen, J. Mattila, I. Rissanen, A. et al. Metabolome and fecal microbiota in monozygotic twin pairs discordant for weight: a Big Mac challenge. FASEB J. 2014, 20, 1-11.
15. Alberti, K. G. Zimmet, P. Shaw, J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366, 1059-1062.
16. Grundy, S. M. Cleeman, J. I. Daniels, S. R. Donato, K. A. et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit. Pathw. Cardiol. 2005, 4, 198-203.
17. Zulet, M. A. Bondia-Pons, I. Abete, I. de la Iglesia, R. et al. The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control. Nutr. Hosp. 2011, 26, 16-26.
18. Bondia-Pons, I. Barri, T. Hanhineva, K. Juntunen, K. et al. UPLC-QTOF/MS metabolic profiling unveils urinary changes in humans after a whole grain rye versus refined wheat bread intervention. Mol. Nutr. Food Res. 2013, 57, 412-422.
19. Schäfer, J. Strimmer, K. An empirical Bayes approach to inferring large-scale gene association networks. Bioinformatics 2005, 21, 754-764.
20. Brohée, S. Faust, K. Lima-Mendez, G. Vanderstocken, G. et al. Network Analysis Tools: from biological networks to clusters and pathways. Nat. Protoc. 2008, 3, 1616-1629.
21. Veilleux, A. Grenier, E. Marceau, P. Carpentier, A. C. et al. Intestinal lipid handling: evidence and implication of insulin signaling abnormalities in human obese subjects. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 644-653.
22. Braverman, N. E. Moser, A. B. Functions of plasmalogen lipids in health and disease. Biochim. Biophys. Acta 2012, 1822, 1442-1452.
23. Wishart, D. S. Jewison, T. Guo, A. C. Wilson, M. et al. HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res. 2013, 41, D801-D807.
24. Heilbronn, L. K. Coster, A. C. Campbell, L. V. Greenfield, J. R. et al. The effect of short-term overfeeding on serum lipids in healthy humans. Obesity 2013, 21, E649-E659.
25. Fan, Y. Y. Chapkin, R. S. Importance of dietary gamma-linoleic acid in human health and nutrition. J. Nutr. 1998, 128, 1411-1414.
26. González-Périz, A. Clària, J. Resolution of adipose tissue inflammation. Sci. World J. 2013, 10, 832-856.
27. Gigliozzi, A. Romeo, R. Fraioli, F. Cantafora, A. et al. Effect of S-adenosyl-L-methionine and dilinoleoylphosphatidylcholine on liver lipid composition and ethanol hepatotoxicity in isolated perfused rat liver. Dig. Dis. Sci. 1998, 43, 2211-2222.
28. Pearce, J. Fatty acid synthesis in liver and adipose tissue. Proc. Nutr. Soc. 1983, 42, 263-271.
29. Garaulet, M. Hernandez-Morante, J. J. Tebar, F. J. Zamora, S. Relation between degree of obesity and site-specific adipose tissue fatty acid composition in a Mediterranean population. Nutrition 2011, 27, 170-176.
30. Zhou, B. R. Zhang, J. A. Zhang, Q. Permatasari, F. et al. Palmitic acid induces production of proinflammatory cytokines interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha via a NF-kappaB-dependent mechanism in HaCaT keratinocytes. Mediators Inflamm. 2013, 2013, 530429.
31. Fattore, E. Fanelli, R. Palm oil and palmitic acid: a review on cardiovascular effects and carcinogenicity. Int. J. Food Sci. Nutr. 2013, 64, 648-659.
32. Benoit, S. C. Kemp, C. J. Elias, C. F. Abplanalp, W. et al. Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents. J. Clin. Invest. 2009, 119, 2577-2589.
33. Perez-Cornago, A. Brennan, L. Ibero-Baraibar, I. Hermsdorff, H. H. et al. Metabolomics identifies changes in fatty acid and amino acid profiles in serum of overweight older adults following a weight loss intervention. J. Physiol. Biochem. 2014, 70, 593-602.
34. Kunesova, M. Hlavaty, P. Tvrzicka, E. Stankova, B. et al. Fatty acid composition of adipose tissue triglycerides after weight loss and weight maintenance: the DIOGENES study. Physiol. Res. 2012, 61, 597-607.
35. Delarue, J. Magnan, C. Free fatty acids and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 2007, 10, 142-148.
36. Masquio, D. C. de Piano, A. Campos, R. M. Sanches, P. L. et al. Saturated fatty acid intake can influence increase in plasminogen activator inhibitor-1 in obese adolescents. Horm. Metab. Res. 2014, 46, 245-251.
37. Browning, L. M. Walker, C. G. Mander, A. P. West, A. L. et al. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am. J. Clin. Nutr. 2012, 96, 748-758.
38. Lorente-Cebrián, S. Costa, A. G. Navas-Carretero, S. Zabala, M. et al. Role of omega-3 fatty acids in obesity, metabolic syndrome, and cardiovascular diseases: a review of the evidence. J. Physiol. Biochem. 2013, 69, 633-651.
39. Alessi, M. C. Juhan-Vague, I. PAI-1 and the metabolic syndrome: links, causes, and consequences. Arterioscler. Thromb. Vasc. Biol. 2006, 26, 2200-2207.
40. Lopez-Legarrea, P. Mansego, M. L. Zulet, M. A. Martinez, J. A. SERPINE1, PAI-1 protein coding gene, methylation levels and epigenetic relationships with adiposity changes in obese subjects with metabolic syndrome features under dietary restriction. J. Clin. Biochem. Nutr. 2013, 53, 139-144.
41. Keller, B. O. Wu, B. T. Li, S. S. Monga, V. et al. Hypaphorine is present in human milk in association with consumption of legumes. J. Agric. Food Chem. 2013, 61, 7654-7660.
42. Bouchenak, M. Lamri-Senhadji, M. Nutritional quality of legumes, and their role in cardiometabolic risk prevention: a review. J. Med. Food 2013, 16, 185-198.
43. Hermsdorff, H. H. Zulet, M. A. Abete, I. Martinez, J. A. A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects. Eur. J. Nutr. 2011, 50, 61-69.
44. Crujeiras, A. B. Parra, D. Abete, I. Martinez, J. A. A hypocaloric diet enriched in legumes specifically mitigates lipid peroxidation in obese subjects. Free Radic. Res. 2007, 41, 498-506.
45. Patino-Alonso, M. C. Recio-Rodríguez, J. I. Magdalena Belio, J. F. Colominas-Garrido, R. et al. Factors associated with adherence to the Mediterranean diet in the adult population. J. Acad. Nutr. Diet. 2014, 114, 583-589.
46. Estruch, R. Salas-Salvadó, J. Towards an even healthier Mediterranean diet. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 1163-1166.
47. Crujeiras, A. B. Parra, D. Milagro, F. I. Goyenechea, E. et al. Differential expression of oxidative stress and inflammation related genes in peripheral blood mononuclear cells in response to a low-calorie diet: a nutrigenomics study. OMICS 2008, 12, 251-261.
48. Hermsdorff, H. H. Zulet, M. A. Abete, I. Martinez, J. A. Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects. Endocrine 2009, 36, 445-451.
49. Abete, I. Goyenechea, E. Zulet, M. A. Martínez, J. A. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr. Metab. Cardiovasc. Dis. 2011, 21(Suppl 2), B1-B15.
50. Varela-Moreiras, G. Ruiz, E. Valero, T. Avila, J. M. et al. The Spanish diet: an update. Nutr. Hosp. 2013, 28(Suppl 5), 13-20.
51. Lopez-Legarrea, P. de la Iglesia, R. Abete, I. Navas-Carretero, S. et al. The effect of short-term overfeeding on serum lipids in healthy humans. Obesity 2013, 21, E649-E659.
52. Lee, C. Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Clin. Chim. Acta 2000, 295, 141-154.
53. Martínez, J. A. Etxeberría, U. Galar, A. Milagro, F. I. Role of dietary polyphenols and inflammatory processes on disease progression mediated by the gut microbiota. Rejuvenation Res. 2013, 16, 435-437.
54. Kovatcheva-Datchary, P. Arora, T. Nutrition, the gut microbiome and the metabolic syndrome. Best Pract. Res. Clin. Gastroenterol. 2013, 27, 59-72.